BELKIN Vision ⚠ Under review

About

Offices

Q&A

What is BELKIN Vision's primary business?

BELKIN Vision is an Israeli medical device company that developed the Eagle device, an automated, non-invasive, and contactless laser surgery for glaucoma, designed to enhance intraocular fluid drainage and lower intraocular pressure.

When was BELKIN Vision acquired and by whom?

BELKIN Vision was acquired by Alcon Pharmaceuticals in July 2024 for an amount of $466,000,000.

What was the most recent funding round for BELKIN Vision?

The most recent funding round for BELKIN Vision was a Grant in December 2021, which secured $19,740,000. The lead investors were European Innovation Council Accelerator and European Innovation Council (EIC).

When did BELKIN Vision receive FDA Clearance for its Eagle device?

BELKIN Vision announced FDA Clearance for its Eagle device in December 2023.

When did BELKIN Vision receive CE Mark under MDR for its Eagle™ device?

BELKIN Vision's Eagle™ device received CE Mark under MDR in May 2022.

What was the total amount raised by BELKIN Vision before its acquisition?

BELKIN Vision raised a total of $42,841,711 across its funding rounds.

Who are the founders of BELKIN Vision?

The founders of BELKIN Vision are Prof. Michael Belkin and Daria Lemann Blumenthal.

What is the employee count for BELKIN Vision?

BELKIN Vision has an employee count in the 11-50 range.

Team · 9

Daria Lemann-Blumenthal

Founder · Chief Executive Officer, Director

Prof. Michael Belkin

Founder · Founder & Medical Director

David Zigdon

Director

Andy Corley

Chairman

Eli Makdasi

Chief Operating Officer

Yoram Solberg

VP Clinical & Medical Affairs

Andrew Webb

Chief Commercial Officer

Tamar Weizman

Director of QA & Regulatory Affairs

Nancy Lebosquain

Director of Communications

Sectors & technology

Highlights

Tags